If your acne keeps coming back, becomes deeper and more painful, or stops responding to standard products, the problem may not be just clogged pores. At Elkhorn Dermatology, we often see patients with resistant cystic acne in Omaha who have already tried cleansers, spot treatments, or even antibiotics without long-term control. In many of these cases, acne appears to be driven by more than surface oil alone. Evidence suggests that persistent inflammatory acne may be influenced by a combination of hormones, sebum, insulin resistance, metabolic stress, microbiome imbalance, and, in some patients, overlap with other inflammatory facial conditions.
If you’re searching for effective treatments for resistant cystic acne, Omaha’s Elkhorn Dermatology are here to help. Ready to get started? Book an acne consultation in Omaha and receive comprehensive care. Call us at 531-777-2752 or book your session online.
Traditional dermatology explains acne through four major processes: follicular plugging, excess sebum production, inflammation, and Cutibacterium acnes-related changes in the follicle. This model remains valid and is still the basis of evidence-based acne treatment.
However, for some patients, especially those with deep cystic lesions, repeated relapses, hormonal flare patterns, or visible inflammatory redness, this traditional model may not fully explain why acne keeps returning. Newer research suggests that metabolic dysfunction and microbiome-related inflammation may help amplify the acne process in some people.
Insulin resistance is one of the most important newer concepts in acne research. A systematic review and meta-analysis in the Journal of the American Academy of Dermatology found an association between acne and insulin resistance, noting that the connection may have diagnostic and therapeutic importance.
Why does this matter? Because insulin and IGF-1 signaling can affect multiple acne pathways at once. These signals can increase androgen activity, stimulate keratinocyte proliferation, and promote sebaceous gland activity. That means metabolic stress can potentially make acne more inflammatory and harder to control. Research also suggests that high-glycemic dietary patterns may worsen acne through insulin-related pathways.
This does not mean every patient with cystic acne has insulin resistance. It does mean that in some patients, especially those with persistent inflammatory acne, irregular eating patterns, sugar cravings, or other metabolic clues, insulin resistance may be part of the picture.
IGF-1 signaling is a vital molecular pathway promoting cell growth, proliferation, survival, and metabolism.
Patients are often told that acne is just caused by “too much oil.” That is incomplete. Sebum remains a central part of acne biology, but modern dermatology recognizes that sebaceous activity is shaped by androgens, inflammation, and metabolic signaling. In other words, the question is not only how much oil the skin makes, but also why the sebaceous gland is being pushed into an acne-promoting state.
Some acne literature also links acne with broader metabolic dysfunction, including insulin resistance and, in some studies, dyslipidemia or metabolic-syndrome features. Evidence for obesity alone is more mixed, but the metabolic link is strong enough that lifestyle and metabolic counseling can be clinically reasonable in selected acne patients.
At Elkhorn Dermatology, this is one reason we do not treat resistant acne as a purely cosmetic oil problem. We consider whether diet-related metabolic stress may be contributing to inflammation beneath the skin. This can include meal skipping, irregular eating patterns, frequent sugar cravings, and a diet high in refined carbohydrates or processed foods, all of which may contribute to blood sugar swings, insulin signaling, and inflammatory activity. We also consider prior or repeated antibiotic exposure, use of multiple medications, and other systemic factors. In some patients, frequent medication use and repeated antibiotic intake may disrupt the gut microbiome and weaken gut barrier function, which may further amplify systemic and skin inflammation.
For years, acne was discussed as if it were simply caused by bacteria. Today, the science is more nuanced. The skin microbiome matters, and newer reviews focus less on the mere presence of C. acnes and more on microbial imbalance, strain differences, biofilm behavior, and inflammation.
This matters clinically because patients can improve briefly on antibiotic-based treatment and then flare again if the deeper drivers of acne remain active. That is why modern acne care still relies heavily on benzoyl peroxide, topical retinoids, and combination therapy, rather than antibiotic-only approaches.
There is also growing interest in the gut-skin axis. Emerging research suggests that gut microbiota may influence systemic inflammation, metabolism, and skin homeostasis, including acne.
Commonly studied strains include Lactobacillus species such as L. rhamnosus and L. acidophilus, as well as Bifidobacterium species. Meta-analyses of randomized controlled trials have reported meaningful improvement in acne severity scores, total lesion counts, and inflammatory markers, with pooled reductions reported at approximately 45% in probiotic groups compared with about 37% in control groups. Some studies suggest that probiotics may be especially helpful for non-inflammatory lesions, while topical probiotic approaches have also shown benefit in reducing erythema, lesion count, and pathogenic bacterial load.
This area is still evolving, and it would be too strong to say that gut dysbiosis causes all acne. A more accurate statement is that digestive health, dietary patterns, and microbiome balance may contribute to inflammatory burden in some patients.
One of the biggest reasons acne becomes frustrating to treat is that some patients do not have pure comedonal acne alone. In clinical practice, some patients show a mixed picture: part classic acne, part more reactive inflammatory facial disease.
Classic acne often begins with comedones—whiteheads or blackheads—that later become inflamed papules or pustules. Rosacea, by contrast, more often presents with central facial redness, flushing, visible superficial vessels, skin sensitivity, and papules or pustules without true comedones. The absence or relative scarcity of comedones can be a useful clue.
At Elkhorn Dermatology, we pay close attention when a patient has:
Those details matter because they may suggest acne with rosacea overlap, or a barrier-reactive inflammatory skin pattern rather than “simple acne only.” Rosacea references from clinical dermatology sources emphasize persistent central facial erythema, flushing, telangiectasia, and papules/pustules without comedones as core clues.
We also look at the patient’s broader inflammatory history. A personal or family background of eczema, seasonal allergies, and reactive skin can suggest a more fragile skin barrier and greater inflammatory sensitivity. When the skin becomes visibly red during basic cleansing, that may be a sign that the patient’s presentation includes more than follicular plugging alone. This does not automatically diagnose rosacea, but it does tell us to be more careful with treatment intensity and barrier support.
Skin imaging can also reinforce this distinction. In some patients, VISIA skin analysis or clinical examination shows both:
That distinction matters because treatment may need to do more than “dry up pimples.” If the skin also has a rosacea-prone, vascular, or barrier-impaired component, overaggressive acne treatment can worsen redness, irritation, and inflammation.
This is one reason Elkhorn Dermatology emphasizes pattern recognition and correct diagnosis. We do not just ask whether a patient has acne. We ask:
Answering those questions helps us choose better treatment. Some patients need classic acne therapies such as benzoyl peroxide, sulfur, salicylic acid, azelaic acid, or retinoids. Others need those same treatments used more carefully, alongside barrier support and inflammation-calming strategies. In selected patients, we also discuss the possible role of the skin microbiome, gut microbiome balance, allergy history, and broader inflammatory health as part of a more integrative dermatologic framework.
In women, resistant acne may sometimes overlap with hormonal and metabolic dysfunction, especially when acne is persistent, cycle-related, lower-face predominant, or associated with signs of androgen excess. Research and women’s health guidance highlight the importance of insulin resistance, hyperandrogenism, and conditions such as PCOS in selected patients.
That does not mean every woman with acne has PCOS or a metabolic disorder. It does mean that for women with premenstrual flares, irregular cycles, cystic jawline acne, or other hormonal clues, acne may reflect a broader endocrine-metabolic pattern that deserves attention.
At Elkhorn Dermatology in Nebraska, we treat acne with a broader, medically grounded approach.
We begin with a careful evaluation of:
When helpful, we use tools such as VISIA, FotoFinder, and dermoscopy image capture for documentation and treatment monitoring. In selected patients, we may also recommend additional diagnostic evaluation to better understand possible internal contributors to persistent or resistant acne. This can include blood work to assess inflammatory or metabolic patterns, hormonal testing when cycle-related or androgen-related acne is suspected, and, in some cases, stool testing when digestive symptoms or broader microbiome concerns are part of the clinical picture. These tools can help us look beyond the visible breakouts and build a more personalized treatment plan.
We use evidence-based acne treatment strategies such as:
Some patients with resistant acne also have disproportionate redness, stinging, or irritation. In those cases, we simplify the skincare routine, reduce exposure to irritating products, and focus on barrier-supportive care while continuing acne treatment.
If the history suggests deeper inflammatory contributors, we may also discuss:
In selected patients, adjunctive microbiome support with oral or topical probiotics, and sometimes prebiotic support, may help improve lesion counts, redness, inflammation, and skin barrier tolerance when used alongside standard acne therapy. This may be especially relevant in patients with digestive symptoms, prior antibiotic exposure, reactive skin, or a history suggesting microbiome disruption.
A broader evaluation may be especially helpful for patients who:
These patterns do not prove one root cause, but they can suggest that acne is being amplified by more than surface oil and clogged pores alone.
Resistant cystic acne is rarely just one thing. Hormones, sebum, follicular plugging, inflammation, microbiome imbalance, metabolic signaling, and sometimes rosacea-prone overlap can all interact. At Elkhorn Dermatology, we believe acne care works best when it is both medically grounded and wide enough to address the bigger picture. We treat the visible breakouts, but we also look for the patterns that may be helping them persist.
If your acne keeps coming back despite standard products, it may be time to look deeper.
This article is for educational purposes only and is not a substitute for medical advice, diagnosis, or treatment. Acne, rosacea, eczema, and other inflammatory facial conditions can overlap. Individual treatment decisions should be made with a qualified medical professional after an in-person evaluation.
If you are dealing with persistent acne, cystic breakouts, facial redness, or repeated treatment failures, schedule an acne consultation with Omaha’s Elkhorn Dermatology. We can help determine whether your skin is showing classic acne, acne with rosacea overlap, or a broader inflammatory pattern that may need a more personalized approach. Call us at 531-777-2752 or book your session online.
